drugset / Trial / NCT00980707
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
Phase 4
Completed
10 enrolled
Associated Scientists to Help Minimize Allergies
Benaroya Research Institute · collabGlaxoSmithKline · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-06
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 220 ug | Inhaled |